Report Detail

Request for Sample of this report

Pharma & Healthcare Global Escitalopram Oxalate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4530860
    • |
  • 16 May, 2023
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Escitalopram Oxalate API market size was valued at USD 66 million in 2022 and is forecast to a readjusted size of USD 102.7 million by 2029 with a CAGR of 6.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of Escitalopram Oxalate API include Zhejiang Huahai, Dr. Reddy's, Shodhana Laboratories, Viatris, Aurobindo, etc. The top five players hold a share over 55%. Asia Pacific dominates the global Escitalopram Oxalate API market, with a share over 50% of the sales in value. In addition, Europe is also an important sales region. In terms of product type, both USDMF and COS/E-DMF is the largest segment, with a share about 90%. In terms of product application, the largest application is depression drug, with a share about 77%, followed by anxiety drug.
Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. The mechanism of antidepressant action of escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
Escitalopram oxalate is an active pharmaceutical ingredient (API) used in the manufacturing of antidepressant medications. Escitalopram oxalate API is a fine white to off-white crystalline powder, which is soluble in water and typically used in tablet form.
This report is a detailed and comprehensive analysis for global Escitalopram Oxalate API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Escitalopram Oxalate API market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2018-2029
Global Escitalopram Oxalate API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2018-2029
Global Escitalopram Oxalate API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2018-2029
Global Escitalopram Oxalate API market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Escitalopram Oxalate API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Escitalopram Oxalate API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sichuan Kelun, Zhejiang Huahai, Haisen Pharma, Viatris and Cipla, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Escitalopram Oxalate API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Both USDMF and COS/E-DM
Only USDMF or COS/E-DM
Market segment by Application
Depression Drug
Anxiety Drug
Major players covered
Sichuan Kelun
Zhejiang Huahai
Haisen Pharma
Viatris
Cipla
Aurobindo
Hetero Labs
Neuland
Smilax Laboratories
Jubilant Generics
Cadila Pharmaceuticals
Natco Pharma
Shodhana Laboratories
Dr. Reddy's
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Escitalopram Oxalate API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Escitalopram Oxalate API, with price, sales, revenue and global market share of Escitalopram Oxalate API from 2018 to 2023.
Chapter 3, the Escitalopram Oxalate API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Escitalopram Oxalate API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Escitalopram Oxalate API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Escitalopram Oxalate API.
Chapter 14 and 15, to describe Escitalopram Oxalate API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Escitalopram Oxalate API
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Escitalopram Oxalate API Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Both USDMF and COS/E-DM
    • 1.3.3 Only USDMF or COS/E-DM
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Escitalopram Oxalate API Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Depression Drug
    • 1.4.3 Anxiety Drug
  • 1.5 Global Escitalopram Oxalate API Market Size & Forecast
    • 1.5.1 Global Escitalopram Oxalate API Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Escitalopram Oxalate API Sales Quantity (2018-2029)
    • 1.5.3 Global Escitalopram Oxalate API Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Sichuan Kelun
    • 2.1.1 Sichuan Kelun Details
    • 2.1.2 Sichuan Kelun Major Business
    • 2.1.3 Sichuan Kelun Escitalopram Oxalate API Product and Services
    • 2.1.4 Sichuan Kelun Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sichuan Kelun Recent Developments/Updates
  • 2.2 Zhejiang Huahai
    • 2.2.1 Zhejiang Huahai Details
    • 2.2.2 Zhejiang Huahai Major Business
    • 2.2.3 Zhejiang Huahai Escitalopram Oxalate API Product and Services
    • 2.2.4 Zhejiang Huahai Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Zhejiang Huahai Recent Developments/Updates
  • 2.3 Haisen Pharma
    • 2.3.1 Haisen Pharma Details
    • 2.3.2 Haisen Pharma Major Business
    • 2.3.3 Haisen Pharma Escitalopram Oxalate API Product and Services
    • 2.3.4 Haisen Pharma Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Haisen Pharma Recent Developments/Updates
  • 2.4 Viatris
    • 2.4.1 Viatris Details
    • 2.4.2 Viatris Major Business
    • 2.4.3 Viatris Escitalopram Oxalate API Product and Services
    • 2.4.4 Viatris Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Viatris Recent Developments/Updates
  • 2.5 Cipla
    • 2.5.1 Cipla Details
    • 2.5.2 Cipla Major Business
    • 2.5.3 Cipla Escitalopram Oxalate API Product and Services
    • 2.5.4 Cipla Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Cipla Recent Developments/Updates
  • 2.6 Aurobindo
    • 2.6.1 Aurobindo Details
    • 2.6.2 Aurobindo Major Business
    • 2.6.3 Aurobindo Escitalopram Oxalate API Product and Services
    • 2.6.4 Aurobindo Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Aurobindo Recent Developments/Updates
  • 2.7 Hetero Labs
    • 2.7.1 Hetero Labs Details
    • 2.7.2 Hetero Labs Major Business
    • 2.7.3 Hetero Labs Escitalopram Oxalate API Product and Services
    • 2.7.4 Hetero Labs Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Hetero Labs Recent Developments/Updates
  • 2.8 Neuland
    • 2.8.1 Neuland Details
    • 2.8.2 Neuland Major Business
    • 2.8.3 Neuland Escitalopram Oxalate API Product and Services
    • 2.8.4 Neuland Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Neuland Recent Developments/Updates
  • 2.9 Smilax Laboratories
    • 2.9.1 Smilax Laboratories Details
    • 2.9.2 Smilax Laboratories Major Business
    • 2.9.3 Smilax Laboratories Escitalopram Oxalate API Product and Services
    • 2.9.4 Smilax Laboratories Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Smilax Laboratories Recent Developments/Updates
  • 2.10 Jubilant Generics
    • 2.10.1 Jubilant Generics Details
    • 2.10.2 Jubilant Generics Major Business
    • 2.10.3 Jubilant Generics Escitalopram Oxalate API Product and Services
    • 2.10.4 Jubilant Generics Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Jubilant Generics Recent Developments/Updates
  • 2.11 Cadila Pharmaceuticals
    • 2.11.1 Cadila Pharmaceuticals Details
    • 2.11.2 Cadila Pharmaceuticals Major Business
    • 2.11.3 Cadila Pharmaceuticals Escitalopram Oxalate API Product and Services
    • 2.11.4 Cadila Pharmaceuticals Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Cadila Pharmaceuticals Recent Developments/Updates
  • 2.12 Natco Pharma
    • 2.12.1 Natco Pharma Details
    • 2.12.2 Natco Pharma Major Business
    • 2.12.3 Natco Pharma Escitalopram Oxalate API Product and Services
    • 2.12.4 Natco Pharma Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Natco Pharma Recent Developments/Updates
  • 2.13 Shodhana Laboratories
    • 2.13.1 Shodhana Laboratories Details
    • 2.13.2 Shodhana Laboratories Major Business
    • 2.13.3 Shodhana Laboratories Escitalopram Oxalate API Product and Services
    • 2.13.4 Shodhana Laboratories Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Shodhana Laboratories Recent Developments/Updates
  • 2.14 Dr. Reddy's
    • 2.14.1 Dr. Reddy's Details
    • 2.14.2 Dr. Reddy's Major Business
    • 2.14.3 Dr. Reddy's Escitalopram Oxalate API Product and Services
    • 2.14.4 Dr. Reddy's Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Dr. Reddy's Recent Developments/Updates

3 Competitive Environment: Escitalopram Oxalate API by Manufacturer

  • 3.1 Global Escitalopram Oxalate API Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Escitalopram Oxalate API Revenue by Manufacturer (2018-2023)
  • 3.3 Global Escitalopram Oxalate API Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Escitalopram Oxalate API by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Escitalopram Oxalate API Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Escitalopram Oxalate API Manufacturer Market Share in 2022
  • 3.5 Escitalopram Oxalate API Market: Overall Company Footprint Analysis
    • 3.5.1 Escitalopram Oxalate API Market: Region Footprint
    • 3.5.2 Escitalopram Oxalate API Market: Company Product Type Footprint
    • 3.5.3 Escitalopram Oxalate API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Escitalopram Oxalate API Market Size by Region
    • 4.1.1 Global Escitalopram Oxalate API Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Escitalopram Oxalate API Consumption Value by Region (2018-2029)
    • 4.1.3 Global Escitalopram Oxalate API Average Price by Region (2018-2029)
  • 4.2 North America Escitalopram Oxalate API Consumption Value (2018-2029)
  • 4.3 Europe Escitalopram Oxalate API Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Escitalopram Oxalate API Consumption Value (2018-2029)
  • 4.5 South America Escitalopram Oxalate API Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Escitalopram Oxalate API Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Escitalopram Oxalate API Sales Quantity by Type (2018-2029)
  • 5.2 Global Escitalopram Oxalate API Consumption Value by Type (2018-2029)
  • 5.3 Global Escitalopram Oxalate API Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Escitalopram Oxalate API Sales Quantity by Application (2018-2029)
  • 6.2 Global Escitalopram Oxalate API Consumption Value by Application (2018-2029)
  • 6.3 Global Escitalopram Oxalate API Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Escitalopram Oxalate API Sales Quantity by Type (2018-2029)
  • 7.2 North America Escitalopram Oxalate API Sales Quantity by Application (2018-2029)
  • 7.3 North America Escitalopram Oxalate API Market Size by Country
    • 7.3.1 North America Escitalopram Oxalate API Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Escitalopram Oxalate API Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Escitalopram Oxalate API Sales Quantity by Type (2018-2029)
  • 8.2 Europe Escitalopram Oxalate API Sales Quantity by Application (2018-2029)
  • 8.3 Europe Escitalopram Oxalate API Market Size by Country
    • 8.3.1 Europe Escitalopram Oxalate API Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Escitalopram Oxalate API Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Escitalopram Oxalate API Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Escitalopram Oxalate API Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Escitalopram Oxalate API Market Size by Region
    • 9.3.1 Asia-Pacific Escitalopram Oxalate API Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Escitalopram Oxalate API Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Escitalopram Oxalate API Sales Quantity by Type (2018-2029)
  • 10.2 South America Escitalopram Oxalate API Sales Quantity by Application (2018-2029)
  • 10.3 South America Escitalopram Oxalate API Market Size by Country
    • 10.3.1 South America Escitalopram Oxalate API Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Escitalopram Oxalate API Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Escitalopram Oxalate API Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Escitalopram Oxalate API Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Escitalopram Oxalate API Market Size by Country
    • 11.3.1 Middle East & Africa Escitalopram Oxalate API Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Escitalopram Oxalate API Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Escitalopram Oxalate API Market Drivers
  • 12.2 Escitalopram Oxalate API Market Restraints
  • 12.3 Escitalopram Oxalate API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Escitalopram Oxalate API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Escitalopram Oxalate API
  • 13.3 Escitalopram Oxalate API Production Process
  • 13.4 Escitalopram Oxalate API Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Escitalopram Oxalate API Typical Distributors
  • 14.3 Escitalopram Oxalate API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Escitalopram Oxalate API. Industry analysis & Market Report on Escitalopram Oxalate API is a syndicated market report, published as Global Escitalopram Oxalate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Escitalopram Oxalate API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo